Clinical trial
A Clinical Study to Assess Single and Repeat Doses of a New Medication…
NCT00459550 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00459550 |
|---|---|
| Title | A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease |
| Official title | A Randomised, Single-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Immunogenicity, Pharmacokinetics and Pharmacodynamics of Intravenous Infusion of GSK933776 in Patients With Alzheimer's Disease. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | GSK933776, Placebo to match GSK933776 |
| Enrollment | 50 |
| Start date | Mar 12, 2007 |
| Primary completion | May 30, 2011 |
| Completion | May 30, 2011 |
| First posted | Apr 12, 2007 |
| Last update posted | Jul 21, 2017 |
| Countries | Australia, Norway, Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: